Surmodics (SRDX) has released an update.
Surmodics, Inc. shareholders convened on February 8, 2024, where they decisively elected all nominated Class I directors and set the board size at six. Additionally, they ratified Deloitte & Touche LLP as their independent auditor for the fiscal year 2024 and endorsed the executive compensation package, affirming their trust in the company’s leadership and financial oversight.
For further insights into SRDX stock, check out TipRanks’ Stock Analysis page.
